- M.D., Stony Brook University
- B.S., Neuroscience and Chemistry, St. Lawrence University
- Residency, Neurology Training Program, Beth Israel Deaconess/Harvard Medical School
- Fellowship, Neuroimmunology/Multiple Sclerosis, Yale University
Areas of expertise
Dr. Levit’s research centers on identifying and validating neuroimaging biomarkers that improve understanding of disease mechanisms and progression in multiple sclerosis, with the goal of translating these insights into more precise and effective patient care.
BIO
Dr. Elle Levit is an Assistant Professor in the Department of Neurological Sciences at the University of Vermont specializing in neuroimmunology and multiple sclerosis. She provides comprehensive, state-of-the-art care for patients with multiple sclerosis and other neuroimmunologic conditions, including individualized treatment planning, advanced disease-modifying therapies, symptom management, and long-term multidisciplinary care focused on preserving function and quality of life.
Publications
Bio
Dr. Elle Levit is an Assistant Professor in the Department of Neurological Sciences at the University of Vermont specializing in neuroimmunology and multiple sclerosis. She provides comprehensive, state-of-the-art care for patients with multiple sclerosis and other neuroimmunologic conditions, including individualized treatment planning, advanced disease-modifying therapies, symptom management, and long-term multidisciplinary care focused on preserving function and quality of life.
Publications
Select Publications
- Levit EM, Horwath EA, Schwartz DL, Silbert LC, Shinohara RT, Solomon AJ. Quantity and Volume of Perivascular Spaces Are Inversely Associated With Multiple Sclerosis Relative to Cerebrovascular Disease and Migraine. Ann Clin Transl Neurol. 2025 Dec;12(12):2569-2574. doi: 10.1002/acn3.70193. Epub 2025 Sep 15. PubMed PMID: 40954941; PubMed Central PMCID: PMC12698934.
- Levit E, Cohen I, Mahajan A, Ulano A, Longbrake EE, Solomon AJ. Evaluation of the relationship between brainstem lesions and apnea hypopnea index in patients with multiple sclerosis. Mult Scler. 2025 Jun;31(7):802-812. doi: 10.1177/13524585251327875. Epub 2025 Mar 29. PubMed PMID: 40156308.
- Levit E, Ren Z, Gonzenbach V, Azevedo CJ, Calabresi PA, Cree BA, Freeman L, Longbrake EE, Oh J, Schindler MK, Sicotte NL, Reich DS, Ontaneda D, Sati P, Cao Q, Shinohara RT, Solomon AJ. Choroid plexus volume differentiates MS from its mimics. Mult Scler. 2024 Jul;30(8):1072-1076. doi: 10.1177/13524585241238094. Epub 2024 Mar 13. PubMed PMID: 38481081; PubMed Central PMCID: PMC11288781.
- Levit E, Longbrake EE, Stoll SS. Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medications. Mult Scler Relat Disord. 2022 Apr;60:103719. doi: 10.1016/j.msard.2022.103719. Epub 2022 Mar 3. PubMed PMID: 35276450; PubMed Central PMCID: PMC8890787.
- Levit E, Cohen I, Dahl M, Edwards K, Weinstock-Guttman B, Ishikawa T, Kavak K, Leavitt V, Nelson K, Onomichi K, Bar-Or A, Perrone C, Riley C, Venkatesh S, De Jager PL, Xia Z, Longbrake EE. Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemic. Mult Scler Relat Disord. 2022 Feb;58:103482. doi: 10.1016/j.msard.2021.103482. Epub 2022 Jan 4. PubMed PMID: 35016114; PubMed Central PMCID: PMC8742609.